Anti-cancer agent comprising HVJ-E and CXCL2
First Claim
Patent Images
1. A method for the prophylaxis or treatment of cancer, comprising administering an effective amount of a pharmaceutical composition comprising the following (1) and (2) to a subject:
- (1) HVJ-E (hemagglutinating virus of Japan envelope),(2) CXCL2 or a nucleic acid comprising a base sequence encoding CXCL2.
2 Assignments
0 Petitions
Accused Products
Abstract
The present invention provides, as a new anti-cancer agent obtained by combining HVJ-E and a molecule synergistically acting therewith, an anti-cancer agent containing the following (1) and (2):
- (1) HVJ-E (hemagglutinating virus of Japan envelope),
- (2) CXCL2, a nucleic acid comprising a base sequence encoding CXCL2 or a CXCL2 expression inducing agent.
0 Citations
12 Claims
-
1. A method for the prophylaxis or treatment of cancer, comprising administering an effective amount of a pharmaceutical composition comprising the following (1) and (2) to a subject:
-
(1) HVJ-E (hemagglutinating virus of Japan envelope), (2) CXCL2 or a nucleic acid comprising a base sequence encoding CXCL2. - View Dependent Claims (3, 4, 5, 6, 7, 8, 9)
-
-
2. A method of inducing an N1 type neutrophil, comprising administering an effective amount a pharmaceutical composition comprising the following (1) and (2) to a subject:
-
(1) HVJ-E (hemagglutinating virus of Japan envelope), (2) CXCL2 or a nucleic acid comprising a base sequence encoding CXCL2. - View Dependent Claims (10, 11, 12)
-
Specification